GlassScriptPhysician profile
Katarzyna Jurecki
NPI 1316386329
$2,218.32
in general payments reported to CMS, 2019-2025
27 companies · $417 in 2025
The $417 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $447 · 2020: $119 · 2021: $154 · 2022: $135 · 2023: $347 · 2024: $600 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,363.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $378.86 | 2019-2025 | |
| Astellas Pharma US INC | $313.48 | 2023-2025 | Veozah, Myrbetriq |
| Minerva Surgical, INC | $176.41 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $169.46 | 2019-2025 | |
| Organon LLC | $168.38 | 2022-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $136.91 | 2021-2024 | Thinprep 2000 Processor, Aptima |
| Shield Therapeutics INC | $117.36 | 2023-2024 | Accrufer |
| Amgen INC. | $102.36 | 2019-2025 | Evenity, Prolia |
| Sage Therapeutics, LLC | $82.18 | 2023-2025 | Zurzuvae |
| Smith+Nephew, INC. | $72.73 | 2025 | Stravix Pl, Oasis |
| Lupin INC. | $53.36 | 2019-2020 | |
| Roche Diagnostics Corporation | $45.74 | 2019 | |
| Ethicon US, LLC | $41.59 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $40.57 | 2021 | |
| Agile Therapeutics, INC. | $40.31 | 2021-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $39.77 | 2019-2023 | Injectafer |
| Exeltis, USA INC. | $33.53 | 2021-2025 | Slynd |
| Radiometer America, INC | $28.63 | 2025 | |
| Pfizer INC. | $27.60 | 2019-2024 | |
| Coopersurgical, INC. | $26.14 | 2020-2022 | |
| Medtronic, INC. | $22.88 | 2025 | Truclear |
| Exact Sciences Corporation | $20.16 | 2024 | Cologuard Collection Kit |
| Meditrina | $19.20 | 2022 | |
| Dexcom, INC. | $17.06 | 2025 | Dexcom G6 Transmitter |
| Scynexis, INC. | $17.01 | 2022 | |
| Avion Pharmaceuticals | $14.11 | 2019 | |
| Allergan, INC. | $12.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katarzyna Jurecki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.